- Previous Close
2.2500 - Open
2.2200 - Bid 1.6000 x 200
- Ask 2.7000 x 200
- Day's Range
2.1400 - 2.3000 - 52 Week Range
1.9600 - 4.1500 - Volume
10,426 - Avg. Volume
19,841 - Market Cap (intraday)
68.236M - Beta (5Y Monthly) 1.09
- PE Ratio (TTM)
-- - EPS (TTM)
-0.1500 - Earnings Date Mar 26, 2025 - Mar 31, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
5.00
Forian Inc. provides a suite of data management capabilities, and information and analytics solutions to optimize and measure operational, clinical, and financial performance for customers in the healthcare and related industries. It develops commercial, real world evidence (RWE), and market access solutions and proprietary data-driven insights, as well as offers data management solutions. The company's subscription and services-based solutions cover the life sciences, pharma services, and healthcare payer and provider industries. Forian Inc. was founded in 2020 and is headquartered in Newtown, Pennsylvania.
forian.com36
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: FORA
View MorePerformance Overview: FORA
Trailing total returns as of 1/31/2025, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: FORA
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: FORA
View MoreValuation Measures
Market Cap
68.24M
Enterprise Value
43.27M
Trailing P/E
75.00
Forward P/E
27.47
PEG Ratio (5yr expected)
0.94
Price/Sales (ttm)
3.48
Price/Book (mrq)
2.54
Enterprise Value/Revenue
2.20
Enterprise Value/EBITDA
20.05
Financial Highlights
Profitability and Income Statement
Profit Margin
9.65%
Return on Assets (ttm)
-6.32%
Return on Equity (ttm)
5.63%
Revenue (ttm)
20.37M
Net Income Avi to Common (ttm)
1.31M
Diluted EPS (ttm)
-0.1500
Balance Sheet and Cash Flow
Total Cash (mrq)
48.01M
Total Debt/Equity (mrq)
94.49%
Levered Free Cash Flow (ttm)
6.89M